Form 4: Core Scientific Director Jordan Levy Receives RSU Grant

Core Scientific director Jordan Levy was granted 18,575 restricted stock units, vesting in February 2027.

Summary

• Jordan Levy, a Director of Core Scientific, Inc. (CORZ), was granted 18,575 restricted stock units (RSUs).
• The RSUs were acquired on February 4, 2026, at a price of $0 per unit.
• These RSUs will vest in full on February 3, 2027, contingent upon Mr. Levy's continued service as a non-employee director.
• Following this transaction, Mr. Levy beneficially owns a total of 325,462 shares of common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents routine director compensation that aligns interests, with minimal immediate impact on company financials or share price.

Positives

• The RSU grant aligns the director's interests with long-term shareholder value through equity ownership.
• The vesting condition incentivizes continued service and commitment from a key board member.

Negatives

• The issuance of new RSUs could lead to minor dilution for existing shareholders upon vesting.

Future Outlook

The RSUs are set to vest on February 3, 2027, provided Jordan Levy continues his service as a non-employee director, indicating an expectation of his continued involvement with the company.

Industry Context

StockSavvy.ai notes that granting restricted stock units to non-employee directors is a common practice across various industries, particularly in technology and growth sectors like cryptocurrency mining, to attract and retain experienced board members and align their interests with long-term company performance.

Comparison to Industry Standards

• The grant of restricted stock units to directors is a standard compensation practice, comparable to similar grants seen at companies like Marathon Digital Holdings (MARA) or Riot Platforms (RIOT) for their non-executive board members, aiming to foster long-term commitment and align interests with shareholders.
• The $0 acquisition price is typical for RSU grants, reflecting compensation rather than a purchase.
• A one-year vesting period (from grant date to vesting date) is also a common structure for director equity awards, balancing retention with performance incentives.

Corporate Governance

Related Party Transactions

• The RSU grant to Director Jordan Levy constitutes a related party transaction, as it involves compensation provided to a member of the company's board of directors.

Stakeholder Impact

• Shareholders: Potential minor dilution upon vesting of RSUs, but also improved alignment of director interests with long-term shareholder value.
• Directors: Provides equity compensation and incentive for continued service.

Next Steps

• Vesting of the 18,575 restricted stock units on February 3, 2027, contingent on Jordan Levy's continued service.

Key Dates

Keywords

Core Scientific, CORZ, Jordan Levy, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, SEC Form 4